0001639837-15-000003.txt : 20150702 0001639837-15-000003.hdr.sgml : 20150702 20150702131741 ACCESSION NUMBER: 0001639837-15-000003 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20150702 DATE AS OF CHANGE: 20150702 EFFECTIVENESS DATE: 20150702 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Triangle Therapeutics Inc. CENTRAL INDEX KEY: 0001639837 IRS NUMBER: 462817645 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-238224 FILM NUMBER: 15968432 BUSINESS ADDRESS: STREET 1: 10900 WILSHIRE BLVD., SUITE 850 CITY: LOS ANGELES STATE: CA ZIP: 90024 BUSINESS PHONE: 310-405-7212 MAIL ADDRESS: STREET 1: 10900 WILSHIRE BLVD., SUITE 850 CITY: LOS ANGELES STATE: CA ZIP: 90024 D/A 1 primary_doc.xml X0707 D/A LIVE 0001639837 Triangle Therapeutics Inc. 10900 WILSHIRE BLVD., SUITE 850 LOS ANGELES CA CALIFORNIA 90024 310-405-7212 CALIFORNIA Triangle Pharmaceuticals Inc. None Corporation true 2013 Carl McKinzie 10900 Wilshire Blvd., Suite 850 Los Angeles CA CALIFORNIA 90024 Executive Officer Director Louis L. Gonda 10900 Wilshire Blvd., Suite 850 Los Angeles CA CALIFORNIA 90024 Director Johannes Czernin 10900 Wilshire Blvd., Suite 850 Los Angeles CA CALIFORNIA 90024 Director Caius Radu 10900 Wilshire Blvd., Suite 850 Los Angeles CA CALIFORNIA 90024 Director Jean deKernion 10900 Wilshire Blvd., Suite 850 Los Angeles CA CALIFORNIA 90024 Director Pharmaceuticals Decline to Disclose 06b true 0001639837-15-000002 2015-04-10 false true true true true false 0 6006000 4854850 1151150 Estimated false 26 0 0 0 false Triangle Therapeutics Inc. Carl McKinzie Carl McKinzie President 2015-07-02